Study of Pharmacodynamics, Pharmacokinetics, Safety and Tolerability of VAY736 in Patients With Idiopathic Pulmonary Fibrosis
Clinical trial NCT03287414 · TERMINATED
Trial details
- NCT number
- NCT03287414
- Sponsor
- Novartis Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-12-20
- Primary completion
- 2020-11-25
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.